- Report
- October 2024
- 193 Pages
Global
From €3399EUR$3,545USD£2,840GBP
€3776EUR$3,939USD£3,155GBP
- Report
- October 2024
- 195 Pages
Global
From €3399EUR$3,545USD£2,840GBP
€3776EUR$3,939USD£3,155GBP
- Report
- July 2024
- 100 Pages
Global
From €5704EUR$5,950USD£4,766GBP
- Report
- April 2025
- 187 Pages
Global
From €4745EUR$4,950USD£3,965GBP
- Report
- April 2025
- 354 Pages
Global
From €5369EUR$5,600USD£4,486GBP
- Report
- April 2023
- 110 Pages
Global
From €4554EUR$4,750USD£3,805GBP
- Report
- December 2022
- 118 Pages
Global
From €4314EUR$4,500USD£3,605GBP
Iron sucrose is a hematological drug used to treat iron deficiency anemia. It is a complex of iron and sucrose, and is administered intravenously. Iron sucrose is used to replenish iron stores in patients with anemia due to chronic kidney disease, and is also used to treat iron deficiency anemia in pregnant women. It is a safe and effective treatment for iron deficiency anemia, and is well tolerated by patients.
Iron sucrose is available in a variety of formulations, including injection, oral, and intravenous solutions. It is available in both generic and branded forms, and is widely available in the United States and other countries.
Several companies manufacture and market iron sucrose, including Vifor Pharma, Fresenius Kabi, and American Regent. Other companies that produce iron sucrose include Hospira, Baxter, and Sandoz. Show Less Read more